Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study.

Journal Article (Clinical Trial;Journal Article)

BACKGROUND: Brainstem gliomas (BSGs) are resistant to all therapy. Based on their imaging characteristics, we postulated that inhibition of P-glycoprotein (P-gp) associated with endothelial cells of the blood-brain barrier might enhance penetration of xenobiotic antineoplastics. PROCEDURE: Seven patients were enrolled in a Phase I study of etoposide, continuous infusion cyclosporine A given with and escalating doses of vincristine and concomitant standard-dose irradiation. RESULTS: Six patients were entered at the first level and one at the second. Closure of the study was mandated by dose-limiting neurotoxicity, consisting of seizures associated with white-matter changes, and alteration of consciousness with bulbar signs. One patient had tumor necrosis at 6 weeks, suggesting some tumor effect. Median survival for the group was 11 months, and for the patients who completed more than 1 month of therapy it was 11 months. CONCLUSION: This regimen proved excessively toxic.

Full Text

Duke Authors

Cited Authors

  • Greenberg, ML; Fisher, PG; Freeman, C; Korones, DN; Bernstein, M; Friedman, H; Blaney, S; Hershon, L; Zhou, T; Chen, Z; Kretschmar, C

Published Date

  • October 15, 2005

Published In

Volume / Issue

  • 45 / 5

Start / End Page

  • 644 - 648

PubMed ID

  • 16110498

International Standard Serial Number (ISSN)

  • 1545-5009

Digital Object Identifier (DOI)

  • 10.1002/pbc.20382


  • eng

Conference Location

  • United States